ClinicalTrials.gg
RecruitingNCT07891845Updated Oct 23, 2026

Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair

An interventional study of Standard TAPP Repair With Complete Hernia Sac Dissection and TAPP Repair With Primary Abandon of the Sac in Indirect Inguinal Hernia, sponsored by Hitit University. Recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Hitit University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Oct 2026).
  • Started Jul 2026; still recruiting 3 months later.
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Sex
All
01

Study summary

This study will compare two ways of managing the hernia sac during laparoscopic surgery for an indirect inguinal hernia, a type of groin hernia. A hernia sac is a pouch of tissue that extends through the hernia opening. In the standard technique, the sac is fully separated from nearby structures and returned to the abdomen. In the alternative technique, called Primary Abandon of the Sac (PAS), the lower part of the sac is left in place to reduce the amount of tissue dissection. Both techniques use mesh to repair the hernia.

The main question is whether leaving the lower part of the sac in place results in an acceptably similar rate of seroma compared with the standard technique. A seroma is a collection of fluid near the area where surgery was performed. The study will also compare operation time, pain, quality of life, complications, return to daily activities, and whether the hernia comes back.

The study plans to enroll 90 adults with a primary indirect inguinal hernia on one side who are scheduled for elective laparoscopic repair. Participants will be assigned by chance to one of the two surgical techniques, with an equal chance of receiving either technique. Participants and the researchers assessing their recovery will not know which technique was used; the operating surgeon will know.

Participants will have follow-up assessments at 1 day, 7 days, 1 month, 6 months, and 12 months after surgery. The main assessment of seroma will take place 30 days after surgery.

Read the detailed description

Brief Summary This study will compare two ways of managing the hernia sac during laparoscopic surgery for an indirect inguinal hernia, a type of groin hernia. A hernia sac is a pouch of tissue that extends through the hernia opening. In the standard technique, the sac is fully separated from nearby structures and returned to the abdomen. In the alternative technique, called Primary Abandon of the Sac (PAS), the lower part of the sac is left in place to reduce the amount of tissue dissection. Both techniques use mesh to repair the hernia.

The main question is whether leaving the lower part of the sac in place results in an acceptably similar rate of seroma compared with the standard technique. A seroma is a collection of fluid near the area where surgery was performed. The study will also compare operation time, pain, quality of life, complications, return to daily activities, and whether the hernia comes back.

The study plans to enroll 90 adults with a primary indirect inguinal hernia on one side who are scheduled for elective laparoscopic repair. Participants will be assigned by chance to one of the two surgical techniques, with an equal chance of receiving either technique. Participants and the researchers assessing their recovery will not know which technique was used; the operating surgeon will know.

Participants will have follow-up assessments at 1 day, 7 days, 1 month, 6 months, and 12 months after surgery. The main assessment of seroma will take place 30 days after surgery.

Detailed Description Management of the distal hernia sac can be technically challenging during laparoscopic repair of indirect inguinal hernias, particularly in large hernias or those extending into the scrotum. Complete dissection may increase manipulation of the spermatic cord, vas deferens, and testicular vessels. The Primary Abandon of the Sac (PAS) technique avoids extensive distal sac dissection by leaving the distal portion in the inguinal canal or scrotum while completing preperitoneal mesh repair. The potential reduction in dissection must be evaluated alongside the risk of postoperative fluid collections.

This single-center, prospective randomized trial uses a non-inferiority design to evaluate PAS against standard transabdominal preperitoneal repair with complete distal sac dissection and reduction. Non-inferiority will be assessed using an absolute margin of 15 percentage points for the difference in seroma rates, defined as the PAS rate minus the standard repair rate, at postoperative day 30.

Allocation will use a computer-generated block randomization sequence with a 1:1 ratio. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes opened after enrollment and written informed consent. Participants and postoperative outcome assessors will be masked to allocation. Operating surgeons cannot be masked because of the nature of the procedures.

Operations will be performed by surgeons experienced in laparoscopic inguinal hernia repair who have completed their learning curve. Mesh use, fixation, and perioperative care will follow standardized surgical principles to limit differences between groups other than distal sac management.

Seroma will be identified by a fluctuant fluid collection on physical examination of the operated inguinal or scrotal region and/or a fluid collection demonstrated by ultrasonography. Ultrasonography will be used when examination findings are uncertain or a fluid collection is clinically suspected.

Pain will be assessed using a 0-10 visual analog scale or numeric rating scale. Hernia-related quality of life will be assessed with the EuraHS-QoL questionnaire before surgery and at postoperative months 1, 6, and 12. Postoperative complications will be graded using the Clavien-Dindo classification. Return to normal daily activities will be recorded as the first day on which the participant can independently perform basic daily activities without a marked increase in analgesic requirements. Recurrence will be defined as a same-side hernia confirmed by clinical examination and/or ultrasonography during the 12-month follow-up period.

Analyses will be performed in both intention-to-treat and per-protocol populations. Continuous variables will be compared using an independent-samples t-test or Mann-Whitney U test, as appropriate for their distribution. Categorical variables will be compared using the chi-square test or Fisher's exact test, as appropriate.

02

Conditions studied

  • Indirect Inguinal Hernia

Browse trials for

Keywords

  • Laparoscopic Inguinal Hernia Repair
  • Transabdominal Preperitoneal Repair
  • TAPP
  • Primary Abandon of the Sac
  • PAS
  • Hernia Sac Management
  • Postoperative Seroma
  • Inguinoscrotal Hernia
  • Non-Inferiority Trial
  • Hernia-Related Quality of Life
03

In context

Hernia, Inguinal

561 studies on the registry are indexed under Hernia, Inguinal; 76 are open to participants now.

This study's planned enrollment of 90 is close to the median of 90 across 414 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Hitit University is the lead sponsor of 84 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Primary unilateral indirect inguinal hernia.
  • Scheduled for elective laparoscopic inguinal hernia repair.
  • Suitable for general anesthesia and laparoscopic surgery.
  • Provision of written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Bilateral inguinal hernia.
  • Recurrent inguinal hernia.
  • Direct inguinal or femoral hernia without a qualifying indirect inguinal hernia.
  • Incarcerated or strangulated hernia requiring emergency surgery.
  • Sliding hernia.
  • Large spermatic cord lipoma.
  • Previous preperitoneal surgery.
  • Contraindication to general anesthesia or laparoscopic surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Standard TAPP Repair

    Participants will undergo laparoscopic transabdominal preperitoneal repair with complete dissection and reduction of the distal hernia sac. Mesh will be placed in the preperitoneal space, followed by peritoneal closure. Mesh fixation and perioperative care will follow standardized procedures.

    Procedure: Standard TAPP Repair With Complete Hernia Sac Dissection

  • Experimental
    Primary Abandon of the Sac (PAS)

    Participants will undergo laparoscopic transabdominal preperitoneal repair using the Primary Abandon of the Sac technique. Extensive distal sac dissection will be avoided, and the distal hernia sac will be left in the inguinal canal or scrotum. Repair will be completed with preperitoneal mesh placement and peritoneal closure. Mesh fixation and perioperative care will follow standardized procedures.

    Procedure: TAPP Repair With Primary Abandon of the Sac

Interventions

  • ProcedureStandard TAPP Repair With Complete Hernia Sac Dissection

    Laparoscopic transabdominal preperitoneal mesh repair involving complete dissection of the distal hernia sac from adjacent cord structures and reduction of the sac into the abdomen.

  • ProcedureTAPP Repair With Primary Abandon of the Sac

    Laparoscopic transabdominal preperitoneal mesh repair in which the distal hernia sac is left in the inguinal canal or scrotum to avoid extensive distal sac dissection.

06

What researchers measure

Primary outcomes

  1. Proportion of Participants With Seroma at Postoperative Day 30

    Percentage of participants with a seroma in the operated inguinal or scrotal region at postoperative day 30. Seroma is defined as a fluctuant fluid collection detected on physical examination and/or a fluid collection demonstrated by ultrasonography. Ultrasonography will be performed when examination findings are uncertain or a seroma is clinically suspected. Seroma rates will be compared between groups to assess non-inferiority of PAS using an absolute margin of 15 percentage points.

    Time frame: Postoperative Day 30

Other outcomes

  1. Operative Time

    Duration of surgery in minutes, measured from the first skin incision to final skin closure.

    Time frame: Intraoperative period, from skin incision to skin closure

  2. Postoperative Pain Score

    Pain intensity measured on a 0-10 visual analog scale or numeric rating scale, where 0 indicates no pain and 10 indicates the worst imaginable pain.

    Time frame: Postoperative Days 1 and 7, and Months 1, 6, and 12

  3. Hernia-Related Quality of Life

    Hernia-related quality of life assessed using the EuraHS-QoL questionnaire, covering pain, activity restriction, and cosmetic discomfort. Higher scores indicate worse quality of life. Postoperative scores will be compared between groups and with baseline values.

    Time frame: Baseline and Postoperative Months 1, 6, and 12

  4. Length of Hospital Stay

    Duration of hospitalization in days following hernia repair, measured from surgery to discharge.

    Time frame: From surgery to hospital discharge, an average of 1 day

  5. Time to Return to Normal Daily Activities

    Number of days from surgery until the participant can independently perform basic daily activities without a marked increase in analgesic requirements.

    Time frame: From surgery through postoperative Month 12

  6. Postoperative Complications

    Percentage of participants experiencing postoperative complications. Complications will be graded according to the Clavien-Dindo classification.

    Time frame: Through postoperative Month 12

  7. Postoperative Hematoma

    Percentage of participants with a hematoma in the operated inguinal or scrotal region.

    Time frame: Through postoperative Month 12

  8. Postoperative Hydrocele

    Percentage of participants with a postoperative hydrocele on the operated side.

    Time frame: Through postoperative Month 12

  9. Postoperative Scrotal Edema

    Percentage of participants with postoperative scrotal edema.

    Time frame: Through postoperative Month 12

  10. Surgical Site Infection

    Percentage of participants with a surgical site infection following hernia repair.

    Time frame: Through postoperative Month 12

  11. Postoperative Testicular Pain

    Percentage of participants reporting testicular pain on the operated side.

    Time frame: Postoperative Days 1 and 7, and Months 1, 6, and 12

  12. Postoperative Urinary Retention

    Percentage of participants experiencing urinary retention following surgery.

    Time frame: Through postoperative Month 12

  13. Chronic Inguinal Pain

    Percentage of participants reporting persistent pain in the operated inguinal region at the 6-month and 12-month follow-up assessments.

    Time frame: Postoperative Months 6 and 12

  14. Hernia Recurrence

    Percentage of participants with a recurrent hernia on the operated side, confirmed by clinical examination and/or ultrasonography.

    Time frame: Through postoperative Month 12

  15. Intraoperative Complications

    Percentage of participants experiencing intraoperative complications, including injury to the spermatic cord, vas deferens, testicular vessels, inferior epigastric vessels, bladder, or bowel, and peritoneal tears.

    Time frame: Intraoperative period, from skin incision to skin closure

  16. Conversion to Open Surgery

    Percentage of participants whose planned laparoscopic repair is converted to open surgery.

    Time frame: Intraoperative period, from skin incision to skin closure

07

Study locations

1 of 1 sites recruiting
  • Hitit University Faculty of Medicine
    Çorum, 19000, Turkey (Türkiye)
    • Veysel Barış TURHAN, MD · Contact · drbaristurhan@hotmail.com · 05079945141
    • Murtaza Salih Kepez, md · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. Study findings will be disseminated through aggregate results in scientific publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jan 2027, 6 months after the start.

Of 181 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's planned 6 months is below that.

Counting every sponsor, half of 190 studies reached it within 17 months; a quarter within 8 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 12, 2026
First posted
Oct 23, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 1, 2028
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891845
Lead sponsor
Hitit University
Responsible party
Veysel Barış TURHAN (Associate Professor of General Surgery, Hitit University) — Principal investigator
First posted
Oct 23, 2026
Start date
Jul 1, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Veysel Barış TURHAN, MD
Contact
drbaristurhan@hotmail.com
+905079945141

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion